1. Home
  2. SEER vs PFO Comparison

SEER vs PFO Comparison

Compare SEER & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$1.95

Market Cap

108.0M

Sector

Health Care

ML Signal

HOLD

Logo Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

PFO

Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

HOLD

Current Price

$9.02

Market Cap

118.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEER
PFO
Founded
2017
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
108.0M
118.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
SEER
PFO
Price
$1.95
$9.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
188.3K
27.1K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
6.51%
EPS Growth
9.40
N/A
EPS
N/A
N/A
Revenue
$16,578,000.00
N/A
Revenue This Year
$2.14
N/A
Revenue Next Year
$25.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.99
N/A
52 Week Low
$1.55
$8.85
52 Week High
$2.41
$9.90

Technical Indicators

Market Signals
Indicator
SEER
PFO
Relative Strength Index (RSI) 39.86 41.28
Support Level $1.83 $8.96
Resistance Level $1.99 $9.26
Average True Range (ATR) 0.04 0.04
MACD -0.01 -0.00
Stochastic Oscillator 16.55 30.77

Price Performance

Historical Comparison
SEER
PFO

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

Share on Social Networks: